Stock News

Heitman Real Estate Securities Has Trimmed Macerich Co. (MAC) Stake by $637,845 as Market Valuation Declined; Sit Investment Associates Has Lowered Its Stake in Thermo Fisher Scientific (TMO) by $453,600 as Market Value Rose

Thermo Fisher Scientific Inc. (NYSE:TMO) Logo

Sit Investment Associates Inc decreased its stake in Thermo Fisher Scientific Inc (TMO) by 5.9% based on its latest 2017Q4 regulatory filing with the SEC. Sit Investment Associates Inc sold 2,400 shares as the company’s stock rose 8.51% while stock markets declined. The institutional investor held 38,282 shares of the industrial machinery and components company at the end of 2017Q4, valued at $7.27M, down from 40,682 at the end of the previous reported quarter. Sit Investment Associates Inc who had been investing in Thermo Fisher Scientific Inc for a number of months, seems to be less bullish one the $86.86 billion market cap company. The stock decreased 0.51% or $1.1 during the last trading session, reaching $215.89. About 1.38 million shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 33.66% since April 21, 2017 and is uptrending. It has outperformed by 22.11% the S&P500.

Heitman Real Estate Securities Llc decreased its stake in Macerich Co. (MAC) by 5.31% based on its latest 2017Q4 regulatory filing with the SEC. Heitman Real Estate Securities Llc sold 9,813 shares as the company’s stock declined 14.88% with the market. The institutional investor held 174,994 shares of the real estate investment trusts company at the end of 2017Q4, valued at $11.49 million, down from 184,807 at the end of the previous reported quarter. Heitman Real Estate Securities Llc who had been investing in Macerich Co. for a number of months, seems to be less bullish one the $8.69 billion market cap company. The stock decreased 0.09% or $0.05 during the last trading session, reaching $57.5. About 3.92M shares traded or 128.09% up from the average. Macerich Company (NYSE:MAC) has declined 12.03% since April 21, 2017 and is downtrending. It has underperformed by 23.58% the S&P500.

Analysts await Macerich Company (NYSE:MAC) to report earnings on April, 26. They expect $0.81 earnings per share, down 6.90% or $0.06 from last year’s $0.87 per share. MAC’s profit will be $122.40 million for 17.75 P/E if the $0.81 EPS becomes a reality. After $1.13 actual earnings per share reported by Macerich Company for the previous quarter, Wall Street now forecasts -28.32% negative EPS growth.

Heitman Real Estate Securities Llc, which manages about $2.16B and $1.75 billion US Long portfolio, upped its stake in Retail Properties Of America Inc (NYSE:RPAI) by 60,512 shares to 3.10M shares, valued at $41.67M in 2017Q4, according to the filing. It also increased its holding in Sabra Health Care Reit Inc (NASDAQ:SBRA) by 497,004 shares in the quarter, for a total of 1.59 million shares, and has risen its stake in Equinix Inc (NASDAQ:EQIX).

Among 24 analysts covering The Macerich Company (NYSE:MAC), 8 have Buy rating, 2 Sell and 14 Hold. Therefore 33% are positive. The Macerich Company had 67 analyst reports since July 21, 2015 according to SRatingsIntel. Sandler O’Neill maintained the shares of MAC in report on Tuesday, January 23 with “Hold” rating. Boenning & Scattergood maintained the stock with “Hold” rating in Friday, August 4 report. The firm has “Underperform” rating by Credit Suisse given on Wednesday, March 16. RBC Capital Markets maintained Macerich Company (NYSE:MAC) rating on Wednesday, October 7. RBC Capital Markets has “Sector Perform” rating and $83 target. The rating was maintained by Jefferies with “Hold” on Sunday, August 20. Canaccord Genuity initiated the stock with “Hold” rating in Wednesday, July 22 report. The stock of Macerich Company (NYSE:MAC) has “Hold” rating given on Monday, March 19 by Sandler O’Neill. The rating was upgraded by Wells Fargo on Tuesday, December 19 to “Outperform”. The stock of Macerich Company (NYSE:MAC) has “Hold” rating given on Monday, March 27 by Canaccord Genuity. Deutsche Bank maintained Macerich Company (NYSE:MAC) on Monday, July 18 with “Hold” rating.

Investors sentiment increased to 1.09 in 2017 Q4. Its up 0.14, from 0.95 in 2017Q3. It is positive, as 28 investors sold MAC shares while 106 reduced holdings. 56 funds opened positions while 90 raised stakes. 135.39 million shares or 0.30% more from 134.98 million shares in 2017Q3 were reported. Qs Investors Ltd Liability Co reported 11,197 shares. Amica Pension Fund Board Of Trustees accumulated 4,162 shares or 0.03% of the stock. United Svcs Automobile Association invested 0.01% of its portfolio in Macerich Company (NYSE:MAC). Aqr Cap Mgmt Ltd invested in 0% or 48,614 shares. Wellington Mngmt Grp Ltd Liability Partnership has 0% invested in Macerich Company (NYSE:MAC). 1,334 are held by Advisory Svcs Networks Limited Liability Com. Amalgamated Bankshares reported 0.03% stake. Daiwa Securities Grp Inc has 0.01% invested in Macerich Company (NYSE:MAC). Cadence Mngmt Limited Liability accumulated 8,175 shares. Security Research & Mgmt invested in 900,348 shares. Oakbrook Invests Ltd holds 0.02% or 4,571 shares. Ulysses Ltd Liability Corporation has invested 2.55% in Macerich Company (NYSE:MAC). Metropolitan Life Ny owns 23,457 shares. 15 are held by Brown Brothers Harriman And. Dekabank Deutsche Girozentrale invested 0.01% of its portfolio in Macerich Company (NYSE:MAC).

Since December 15, 2017, it had 0 insider buys, and 8 insider sales for $37.14 million activity. Herrema Gregory J. had sold 33,327 shares worth $7.32 million on Friday, February 2. CASPER MARC N had sold 50,000 shares worth $9.59 million. Durbin Patrick M sold $1.31 million worth of Thermo Fisher Scientific Inc. (NYSE:TMO) on Monday, February 5. Williamson Stephen sold $511,511 worth of stock.

Sit Investment Associates Inc, which manages about $6.54 billion and $4.19 billion US Long portfolio, upped its stake in Invesco Van Kampen High Inc Ii (VLT) by 72,149 shares to 174,793 shares, valued at $2.57M in 2017Q4, according to the filing. It also increased its holding in Qts Realty Tr Inc (NYSE:QTS) by 9,165 shares in the quarter, for a total of 27,550 shares, and has risen its stake in Brinks Co (NYSE:BCO).

Among 19 analysts covering Thermo Fisher Scientific (NYSE:TMO), 18 have Buy rating, 0 Sell and 1 Hold. Therefore 95% are positive. Thermo Fisher Scientific had 62 analyst reports since July 24, 2015 according to SRatingsIntel. Cowen & Co maintained it with “Buy” rating and $220.0 target in Wednesday, October 11 report. Cleveland downgraded the stock to “Neutral” rating in Friday, September 9 report. The firm has “Hold” rating by Jefferies given on Thursday, March 30. The company was maintained on Wednesday, April 11 by Morgan Stanley. Mizuho maintained the stock with “Buy” rating in Tuesday, May 3 report. The rating was initiated by Goldman Sachs with “Buy” on Tuesday, September 26. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) has “Buy” rating given on Monday, October 2 by Robert W. Baird. The firm earned “Buy” rating on Tuesday, October 6 by Argus Research. The company was maintained on Thursday, July 23 by Mizuho. As per Monday, January 11, the company rating was maintained by Stifel Nicolaus.

Macerich Company (NYSE:MAC) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *